Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Joshua Kennedy

Concepts (223)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhinovirus
11
2022
24
3.810
Why?
Asthma
15
2022
240
3.700
Why?
Picornaviridae Infections
8
2022
19
3.260
Why?
Rhinitis
5
2018
30
2.950
Why?
Sinusitis
5
2018
47
2.860
Why?
Desensitization, Immunologic
5
2018
98
2.420
Why?
Drug Hypersensitivity
3
2018
43
1.500
Why?
Respiratory Hypersensitivity
4
2020
21
1.320
Why?
Disaccharides
2
2015
11
1.150
Why?
Lung
2
2019
483
1.140
Why?
Immunoglobulin E
8
2020
86
1.140
Why?
Rhinitis, Allergic, Perennial
2
2014
4
1.130
Why?
Urticaria
2
2015
23
1.130
Why?
Androstadienes
2
2014
11
1.130
Why?
Hypersensitivity
5
2019
62
1.120
Why?
Meat
2
2015
58
1.120
Why?
Rhinitis, Allergic, Seasonal
2
2014
6
1.120
Why?
Carbachol
3
2020
38
0.970
Why?
Allergens
6
2019
122
0.820
Why?
Eosinophils
3
2017
38
0.810
Why?
Th2 Cells
2
2016
24
0.800
Why?
Bronchoconstriction
1
2019
12
0.780
Why?
Respiratory Sounds
3
2020
45
0.770
Why?
Anaphylaxis
2
2018
69
0.770
Why?
Aspirin
2
2017
132
0.740
Why?
Bronchodilator Agents
2
2019
76
0.730
Why?
Mesalamine
1
2017
9
0.690
Why?
Ketorolac
1
2016
2
0.680
Why?
Colitis, Ulcerative
1
2017
50
0.660
Why?
Itraconazole
1
2016
41
0.660
Why?
Food Hypersensitivity
2
2019
90
0.660
Why?
Staphylococcus
2
2013
36
0.650
Why?
Viral Load
3
2022
86
0.650
Why?
Humans
35
2022
50276
0.620
Why?
Immunologic Factors
1
2016
123
0.610
Why?
Acetaminophen
1
2019
344
0.590
Why?
Allergy and Immunology
1
2013
17
0.540
Why?
Candidiasis
1
2014
114
0.530
Why?
Hypersensitivity, Delayed
1
2013
21
0.530
Why?
Manikins
1
2013
35
0.530
Why?
Lymphangitis
1
2013
2
0.530
Why?
Emergency Medicine
1
2013
57
0.520
Why?
Eosinophilia
1
2013
31
0.500
Why?
Bronchi
1
2012
53
0.490
Why?
Common Cold
1
2012
4
0.490
Why?
Pruritus
1
2013
45
0.490
Why?
Edema
1
2013
63
0.490
Why?
Chronic Disease
4
2016
611
0.450
Why?
Animals
11
2020
14247
0.410
Why?
Pediatrics
1
2013
302
0.400
Why?
Staphylococcal Infections
1
2013
291
0.400
Why?
Male
16
2021
27231
0.380
Why?
Anti-Allergic Agents
2
2020
13
0.380
Why?
Diagnosis, Differential
3
2018
1151
0.360
Why?
Anti-Bacterial Agents
1
2013
756
0.340
Why?
Female
15
2021
27910
0.330
Why?
Adolescent
9
2019
6596
0.320
Why?
Child
8
2019
6482
0.320
Why?
Disease Progression
3
2020
867
0.310
Why?
Interleukins
2
2015
42
0.280
Why?
Young Adult
4
2020
4120
0.260
Why?
Skin Tests
2
2013
57
0.260
Why?
Adult
8
2022
13861
0.260
Why?
Swine
2
2015
410
0.260
Why?
Respiratory Tract Infections
2
2020
77
0.240
Why?
Middle Aged
5
2019
13149
0.220
Why?
Autoantibodies
1
2021
122
0.220
Why?
Enterovirus
1
2020
8
0.210
Why?
Enterovirus Infections
1
2020
6
0.210
Why?
Respiratory System
1
2020
27
0.210
Why?
Virus Diseases
1
2020
30
0.210
Why?
Muscle, Smooth
1
2020
84
0.200
Why?
Calcium Signaling
1
2020
60
0.200
Why?
Organ Culture Techniques
1
2019
55
0.190
Why?
Disease Susceptibility
1
2019
97
0.190
Why?
Nasal Polyps
1
2018
5
0.190
Why?
Mice, Inbred Strains
1
2019
207
0.190
Why?
Child, Preschool
4
2019
3972
0.190
Why?
Acetazolamide
1
2018
21
0.190
Why?
Pseudotumor Cerebri
1
2018
24
0.180
Why?
Albuterol
1
2019
58
0.180
Why?
RNA, Viral
2
2020
128
0.180
Why?
Food Supply
1
2019
86
0.180
Why?
Treatment Outcome
5
2018
5421
0.180
Why?
Parainfluenza Virus 3, Human
1
2017
7
0.170
Why?
Respirovirus Infections
1
2017
8
0.170
Why?
Host-Pathogen Interactions
1
2019
148
0.170
Why?
Cross-Sectional Studies
3
2022
1468
0.170
Why?
Th1-Th2 Balance
1
2016
2
0.170
Why?
Immunization
2
2017
84
0.170
Why?
Eosinophilic Esophagitis
1
2017
38
0.170
Why?
Anticonvulsants
1
2018
132
0.170
Why?
Leukotrienes
1
2016
9
0.170
Why?
Prevalence
2
2019
944
0.170
Why?
Health Literacy
1
2019
122
0.170
Why?
Esophagus
1
2017
94
0.160
Why?
Immunocompromised Host
1
2017
130
0.160
Why?
Cells, Cultured
2
2020
1787
0.160
Why?
Lymphocyte Activation
1
2016
211
0.160
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
146
0.150
Why?
Genetic Predisposition to Disease
1
2019
564
0.150
Why?
High-Throughput Nucleotide Sequencing
1
2017
194
0.150
Why?
Intracellular Membranes
1
1995
28
0.150
Why?
Candidiasis, Chronic Mucocutaneous
1
2014
2
0.150
Why?
Basophils
1
2014
17
0.150
Why?
Myoglobin
1
1995
25
0.150
Why?
Thymoma
1
2014
11
0.140
Why?
Interleukin-17
1
2015
40
0.140
Why?
Arkansas
3
2019
2133
0.140
Why?
Eosinophil Cationic Protein
1
2014
1
0.140
Why?
Nasal Lavage Fluid
1
2014
8
0.140
Why?
Dose-Response Relationship, Drug
1
2019
1550
0.140
Why?
Decision Making, Computer-Assisted
1
2014
4
0.140
Why?
Interferons
1
2014
36
0.140
Why?
Candida
1
2014
61
0.140
Why?
Administration, Intranasal
1
2014
28
0.140
Why?
Superantigens
1
2013
1
0.140
Why?
Leukocyte Count
1
2014
82
0.140
Why?
Intercellular Adhesion Molecule-1
1
2014
75
0.140
Why?
Markov Chains
1
2014
35
0.140
Why?
Nasal Mucosa
1
2013
21
0.140
Why?
Emergency Treatment
1
2013
35
0.130
Why?
Angioedema
1
2013
5
0.130
Why?
Virginia
1
2013
14
0.130
Why?
Preoperative Period
1
2013
61
0.130
Why?
Antibodies, Anti-Idiotypic
1
2013
30
0.130
Why?
Cats
1
2013
57
0.130
Why?
Paranasal Sinuses
1
2013
23
0.130
Why?
Cough
1
2013
51
0.130
Why?
Decision Support Techniques
1
2014
83
0.130
Why?
Cell Differentiation
1
2016
750
0.130
Why?
Case-Control Studies
2
2014
1224
0.130
Why?
Affect
1
2013
102
0.130
Why?
Dogs
1
2013
209
0.130
Why?
Postoperative Period
1
2013
182
0.130
Why?
Oxidative Stress
1
2019
937
0.130
Why?
Mice, Inbred C57BL
1
2019
2022
0.130
Why?
Sex Distribution
1
2013
155
0.130
Why?
Age Distribution
1
2013
193
0.130
Why?
Cattle
1
2013
214
0.130
Why?
Acute Disease
1
2014
411
0.120
Why?
Statistics, Nonparametric
1
2013
236
0.120
Why?
Pyroglyphidae
1
2012
2
0.120
Why?
Cost-Benefit Analysis
1
2014
273
0.120
Why?
Equipment Design
1
2013
328
0.120
Why?
Polymerase Chain Reaction
1
2014
532
0.120
Why?
Oxygen
1
1995
345
0.120
Why?
Age Factors
2
2014
1226
0.120
Why?
Odds Ratio
1
2014
606
0.120
Why?
Myocardium
1
1995
415
0.120
Why?
Biofilms
1
2013
204
0.110
Why?
Prospective Studies
2
2017
2349
0.110
Why?
Virulence
1
2012
180
0.110
Why?
Bacteria
1
2013
226
0.110
Why?
Patient Care Team
1
2013
288
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2013
219
0.110
Why?
Cytokines
1
2015
671
0.110
Why?
Logistic Models
1
2014
1001
0.110
Why?
Clinical Competence
1
2013
430
0.100
Why?
Incidence
1
2013
1051
0.100
Why?
Cohort Studies
1
2013
1444
0.090
Why?
Tomography, X-Ray Computed
1
2014
1235
0.090
Why?
Hospitalization
1
2013
649
0.090
Why?
Genome, Viral
2
2020
88
0.090
Why?
Time Factors
2
2013
3352
0.090
Why?
Risk Assessment
1
2013
1387
0.090
Why?
Prognosis
1
2013
2057
0.090
Why?
United States
1
2016
4825
0.080
Why?
Respiratory Function Tests
2
2020
101
0.070
Why?
Multiple Myeloma
1
2017
2686
0.060
Why?
Seroepidemiologic Studies
1
2022
44
0.060
Why?
Peptidyl-Dipeptidase A
1
2021
23
0.060
Why?
Renin-Angiotensin System
1
2021
51
0.060
Why?
Receptor, Angiotensin, Type 1
1
2021
60
0.060
Why?
Immunity, Innate
1
2022
107
0.050
Why?
Myosin Light Chains
1
2020
5
0.050
Why?
Chemokine CXCL10
1
2020
19
0.050
Why?
Placebo Effect
1
2020
20
0.050
Why?
Angiotensin II
1
2021
139
0.050
Why?
Histamine
1
2020
28
0.050
Why?
Primary Prevention
1
2020
48
0.050
Why?
Muscle Contraction
1
2020
115
0.050
Why?
Tertiary Healthcare
1
2019
19
0.050
Why?
Myocytes, Smooth Muscle
1
2020
109
0.050
Why?
Inflammation Mediators
1
2020
143
0.050
Why?
Hypersensitivity, Immediate
1
2018
13
0.050
Why?
Protein Processing, Post-Translational
1
2020
178
0.050
Why?
Coculture Techniques
1
2018
161
0.050
Why?
Air Pollutants
1
2018
61
0.050
Why?
Phosphorylation
1
2020
620
0.050
Why?
Immune Tolerance
1
2018
104
0.050
Why?
Double-Blind Method
1
2020
733
0.040
Why?
Particulate Matter
1
2017
52
0.040
Why?
Seasons
1
2017
79
0.040
Why?
Proton Pump Inhibitors
1
2017
89
0.040
Why?
Cross Infection
1
2017
103
0.040
Why?
Partial Pressure
1
1995
18
0.040
Why?
Phosphorus
1
1995
28
0.040
Why?
Environmental Exposure
1
2017
208
0.040
Why?
Receptors, Cytokine
1
2014
12
0.040
Why?
Longitudinal Studies
1
2017
668
0.040
Why?
Protons
1
1995
68
0.040
Why?
Magnetic Resonance Spectroscopy
1
1995
243
0.030
Why?
Protein-Tyrosine Kinases
1
2014
103
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2014
139
0.030
Why?
Adenosine Triphosphate
1
1995
228
0.030
Why?
Quality of Life
1
2019
728
0.030
Why?
Exhalation
1
2012
18
0.030
Why?
Epitopes
1
2012
84
0.030
Why?
Risk
1
2012
342
0.030
Why?
Rats, Sprague-Dawley
1
1995
1729
0.030
Why?
Infant
1
2019
3499
0.030
Why?
Nitric Oxide
1
2012
282
0.030
Why?
Risk Factors
1
2019
3860
0.030
Why?
Spirometry
1
2008
30
0.020
Why?
Respiratory Therapy
1
2008
36
0.020
Why?
Adrenal Cortex Hormones
1
2008
81
0.020
Why?
Rats
1
1995
3430
0.020
Why?
Administration, Oral
1
2008
459
0.020
Why?
Retrospective Studies
1
2017
5676
0.020
Why?
Practice Guidelines as Topic
1
2008
522
0.020
Why?
Severity of Illness Index
1
2008
1063
0.020
Why?
Follow-Up Studies
1
2008
2357
0.020
Why?
Kennedy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description